Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 58.97%-32.46K | 125.55%10.56K | 88.27%-48.03K | -237.10%-623.93K | -54.82%-94.16K | -360.36%-79.11K | -30.48%-41.32K | -232.82%-409.34K | 81.80%-185.09K | 75.86%-60.82K |
| Net income from continuing operations | 64.39%-42.82K | 22.64%-93.04K | 38.00%-81K | 28.33%-563.85K | 28.02%-192.7K | 15.21%-120.24K | -2.69%-120.27K | 49.77%-130.65K | 77.55%-786.72K | 16.49%-267.71K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10.55K | ---13.39K |
| Depreciation and amortization | --0 | 800.16%22.33K | -0.04%2.48K | 0.00%9.93K | 0.00%2.48K | 0.00%2.48K | -0.04%2.48K | 0.04%2.48K | -23.25%9.93K | 1,460.38%2.48K |
| Remuneration paid in stock | ---- | ---- | ---- | -31.32%48.5K | --48.5K | --0 | --0 | --0 | -84.09%70.62K | --0 |
| Other non cashItems | --0 | -22.07%1.05K | -99.65%1.14K | -9.67%5.19K | -43,511.08%-356.41K | 2,003.56%33.07K | -18.33%1.34K | 19,067.14%327.18K | -99.70%5.74K | -99.62%821 |
| Change In working capital | 85.61%10.36K | 6.77%80.22K | 104.82%29.35K | -124.00%-123.69K | 77.54%403.96K | -96.69%5.58K | 716.71%75.13K | -652.97%-608.36K | 320.14%515.35K | 974.68%227.53K |
| -Change in receivables | 89.99%-615 | -73.63%7.77K | 97.44%-569 | -92.22%3.06K | -84.10%2K | -112.02%-6.14K | 299.74%29.45K | -129.17%-22.25K | 229.63%39.24K | 162.19%12.58K |
| -Change in prepaid assets | --0 | --0 | --0 | 341.08%8.4K | 100.03%4 | -87.03%1.04K | -51.45%1.44K | 2,698.68%5.93K | 28.21%-3.49K | 91.93%-14.21K |
| -Change in payables and accrued expense | 2.69%10.98K | 63.76%72.45K | 105.05%29.92K | -128.18%-135.15K | 75.40%401.95K | -90.24%10.69K | 110.89%44.24K | -593.55%-592.03K | 203.94%479.6K | 34.58%229.16K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 58.97%-32.46K | 125.55%10.56K | 88.27%-48.03K | -237.10%-623.93K | -54.82%-94.16K | -360.36%-79.11K | -30.48%-41.32K | -232.82%-409.34K | 81.80%-185.09K | 75.86%-60.82K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -407.71%-18.04K | -100.52%-3.62K | 354.16%689.98K | -110.49%-3.62K | -2.87%-3.62K | -2.99%-3.55K | 463.39%700.78K | -29.61%151.93K | -84.01%34.51K |
| Net issuance payments of debt | 376.09%10K | -689.16%-28.04K | -2.81%-3.62K | -2.95%-14.32K | -2.78%-3.62K | -2.90%-3.62K | -2.99%-3.55K | -3.13%-3.52K | 29.30%-13.91K | 82.10%-3.52K |
| Net common stock issuance | --0 | --0 | --0 | 324.71%704.3K | --0 | --0 | --0 | 451.10%704.3K | -29.58%165.83K | -83.85%38.03K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -407.71%-18.04K | -100.52%-3.62K | 354.16%689.98K | -110.49%-3.62K | -2.87%-3.62K | -2.99%-3.55K | 463.39%700.78K | -29.61%151.93K | -84.01%34.51K |
| Net cash flow | ||||||||||
| Beginning cash position | -94.32%14.77K | -93.92%19.2K | 196.36%73.97K | -27.11%24.96K | 501.49%164.73K | 49,577.44%259.81K | 786.14%315.79K | -27.11%24.96K | -95.90%34.24K | -61.46%27.39K |
| Current changes in cash | 60.76%-32.46K | 83.33%-7.48K | -117.72%-51.65K | 299.19%66.05K | -271.70%-97.78K | -407.97%-82.73K | -27.78%-44.87K | 20,806.53%291.44K | 95.86%-33.16K | 27.04%-26.31K |
| Effect of exchange rate changes | 284.71%22.81K | 127.42%3.05K | -410.31%-3.12K | -171.38%-17.05K | -70.60%7.02K | ---12.35K | ---11.1K | ---611 | 3,225.52%23.88K | --23.88K |
| End cash Position | -96.89%5.12K | -94.32%14.77K | -93.92%19.2K | 196.36%73.97K | 196.36%73.97K | 501.49%164.73K | 49,577.44%259.81K | 786.14%315.79K | -27.11%24.96K | -27.11%24.96K |
| Free cash from | 58.97%-32.46K | 125.55%10.56K | 88.27%-48.03K | -237.10%-623.93K | -54.82%-94.16K | -360.36%-79.11K | -30.48%-41.32K | -232.82%-409.34K | 81.80%-185.09K | 75.86%-60.82K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.